Search Results - "DAYANANDAN, R"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation by Dayanandan, R., Van Slegtenhorst, M., Mack, T.G.A., Ko, L., Yen, S.-H., Leroy, K., Brion, J.-P., Anderton, B.H., Hutton, M., Lovestone, S.

    Published in FEBS letters (12-03-1999)
    “…In vitro evidence has suggested a change in the ability of tau bearing mutations associated with fronto-temporal dementia to promote microtubule assembly. We…”
    Get full text
    Journal Article
  5. 5

    Screening for problem drinking in older people referred to a mental health service: A comparison of CAGE and AUDIT by Philpot, M., Pearson, N., Petratou, V., Dayanandan, R., Silverman, M., Marshall, J.

    Published in Aging & mental health (01-05-2003)
    “…The aim of the study was to evaluate the validity of the Alcohol Use Disorders Identification Test (AUDIT), the five-item version (AUDIT-5) and the CAGE as…”
    Get full text
    Journal Article
  6. 6

    Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons by FORLENZA, O. V, SPINK, J. M, DAYANANDAN, R, ANDERTON, B. H, OLESEN, O. F, LOVESTONE, S

    Published in Journal of Neural Transmission (25-10-2000)
    “…Muscarinic agonists alter the metabolism of amyloid precursor protein, leading to an increase in alpha -secretase cleavage and a decreased production of…”
    Get full text
    Journal Article
  7. 7

    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease by Bowman, Louise, Hopewell, Jemma C, Chen, Fang, Wallendszus, Karl, Stevens, William, Collins, Rory, Wiviott, Stephen D, Cannon, Christopher P, Braunwald, Eugene, Sammons, Emily, Landray, Martin J

    Published in The New England journal of medicine (28-09-2017)
    “…In this trial involving patients with atherosclerotic disease who were receiving effective statin therapy, those who were assigned to receive anacetrapib, a…”
    Get full text
    Journal Article
  8. 8

    Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells by Mack, T.G.A, Dayanandan, R, Van Slegtenhorst, M, Whone, A, Hutton, M, Lovestone, S, Anderton, B.H

    Published in Neuroscience (01-01-2001)
    “…The inherited form of frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) has been attributed to mutations in the tau gene…”
    Get full text
    Journal Article
  9. 9

    The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3β activity by Leroy, K., Menu, R., Conreur, J.L., Dayanandan, R., Lovestone, S., Anderton, B.H., Brion, J.P.

    Published in FEBS letters (07-01-2000)
    “…The microtubule-associated protein tau favors microtubule nucleation and stabilization and plays a role in the elongation of axons. We have investigated the…”
    Get full text
    Journal Article
  10. 10

    Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial by Armitage, Jane, Bowman, Louise, Wallendszus, Karl, Bulbulia, Richard, Rahimi, Kazem, Haynes, Richard, Parish, Sarah, Peto, Richard, Collins, Rory

    Published in The Lancet (British edition) (13-11-2010)
    “…Summary Background Lowering of LDL cholesterol reduces major vascular events, but whether more intensive therapy safely produces extra benefits is uncertain…”
    Get full text
    Journal Article
  11. 11

    Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data

    Published in Nephrology, dialysis, transplantation (01-12-2017)
    “…Patients with chronic kidney disease (CKD) are at risk of progression to end-stage renal disease and cardiovascular disease. Data from other populations and…”
    Get full text
    Journal Article
  12. 12

    Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells by Ljungberg, M.C, Asuni, A, Pearce, J, Dayanandan, R, März, W, Hoffmann, M.M, Bertrand, P, Siest, G, Rupniak, H.T.R, Anderton, B.H, Huettinger, M, Lovestone, S

    Published in Neuroscience letters (24-04-2003)
    “…As part of investigations of the cellular uptake of apolipoprotein E (apoE) relevant to Alzheimer's disease we have found that different preparations of apoE…”
    Get full text
    Journal Article
  13. 13
  14. 14

    089 Delayed primary CNS post-transplant lymphoproliferative disorder (PTLD) by Chhetri, S K, Dayanandan, R, Joseph, J, Armour, A, Sonwalkar, H, Emsley, H C A

    “…Primary central nervous system (PCNS) PTLD is a very rare complication that occurs as a result of immunosuppression in the setting of solid organ…”
    Get full text
    Journal Article
  15. 15

    Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer’s disease? by Anderton, Brian H, Dayanandan, Rejith, Killick, Richard, Lovestone, Simon

    Published in Molecular medicine today (Regul. ed.) (01-02-2000)
    “…Alzheimer’s disease is characterized by the presence of neurofibrillary tangles and senile neuritic plaques in the brain. Tangles are aggregates of paired…”
    Get full text
    Journal Article
  16. 16

    Studies on RDX Particle Size in LOVA Gun Propellant Formulations by Pillai, A. G. S., Sanghavi, R. R., Dayanandan, C. R., Joshi, M. M., Velapure, S. P., Singh, Amarjit

    Published in Propellants, explosives, pyrotechnics (01-12-2001)
    “…This paper presents the results of systematic studies carried out on the role of fine RDX in determining the burning rate and ballistics of LOVA gun…”
    Get full text
    Journal Article
  17. 17

    Truncated apoE forms tangle-like structures in a neuronal cell line by Ljungberg, M Cecilia, Dayanandan, Rejith, Asuni, Ayodeji, Rupniak, Tom H, Anderton, Brian H, Lovestone, Simon

    Published in Neuroreport (07-05-2002)
    “…Apolipoprotein E is the predominant brain lipoprotein and polymorphic variation in the APOE gene the major genetic susceptibly factor for late onset…”
    Get full text
    Journal Article
  18. 18

    Neurofibrillary tangles and tau phosphorylation by Brion, J P, Anderton, B H, Authelet, M, Dayanandan, R, Leroy, K, Lovestone, S, Octave, J N, Pradier, L, Touchet, N, Tremp, G

    Published in Biochemical Society Symposia (01-01-2001)
    “…Neurofibrillary tangles (NFTs) are a characteristic neuropathological lesion of Alzheimer's disease (AD). They are composed of a highly-phosphorylated form of…”
    Get more information
    Journal Article
  19. 19

    Sites of phosphorylation in tau and factors affecting their regulation by Anderton, B H, Betts, J, Blackstock, W P, Brion, J P, Chapman, S, Connell, J, Dayanandan, R, Gallo, J M, Gibb, G, Hanger, D P, Hutton, M, Kardalinou, E, Leroy, K, Lovestone, S, Mack, T, Reynolds, C H, Van Slegtenhorst, M

    Published in Biochemical Society Symposia (01-01-2001)
    “…The microtubule-associated protein, tau, is the principal component of paired helical filaments (PHFs) in Alzheimer's disease. PHF-tau is highly phosphorylated…”
    Get more information
    Journal Article
  20. 20

    The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity by Leroy, K, Menu, R, Conreur, J L, Dayanandan, R, Lovestone, S, Anderton, B H, Brion, J P

    Published in FEBS letters (07-01-2000)
    “…The microtubule-associated protein tau favors microtubule nucleation and stabilization and plays a role in the elongation of axons. We have investigated the…”
    Get full text
    Journal Article